SCHEMBL24656014

SCHEMBL24656014

Cc1nc(C)nc(-c2cc(-n3c4ccccc4c4ccc(-c5ccccc5)cc43)c(C#N)c(-n3c4ccccc4c4ccc(-c5ccccc5)cc43)c2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
HIF1A Q16665 1/20 0.35
KDM5B Q9UGL1 2/20 0.35
KDM4A O75164 1/20 0.35
PDE9A O76083 1/20 0.34
PDE1C Q14123 1/20 0.34
ADORA1 P30542 3/20 0.33
KDM4E B2RXH2 3/20 0.33
HPGD P15428 3/20 0.33
ADORA2A P29274 2/20 0.33
ALDH1A1 P00352 2/20 0.33
PPARG P37231 1/20 0.33
NCOA2 Q15596 1/20 0.33
NCOA1 Q15788 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
CYP11B2 P19099 1/20 0.33
HSD17B10 Q99714 1/20 0.33
SQOR Q9Y6N5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19942756 0.97 L3MBTL1 (0.39) L3MBTL1SMN1; SMN2HIF1AKDM5BKDM4A
SCHEMBL19942761 0.95 L3MBTL1 (0.38) L3MBTL1SMN1; SMN2HIF1AKDM5BKDM4A
SCHEMBL19943082 0.94 L3MBTL1 (0.41) L3MBTL1SMN1; SMN2HIF1APDE9APDE1C
SCHEMBL21108785 0.94 PDE1C (0.38) L3MBTL1SMN1; SMN2HIF1APDE9APDE1C
SCHEMBL19943081 0.94 PDE9A (0.34) L3MBTL1SMN1; SMN2HIF1APDE9APDE1C
SCHEMBL19942693 0.94 PTGER4 (0.38) MEN1KMT2A
SCHEMBL19942677 0.93 KDM4A (0.39) SMN1; SMN2HIF1AKDM5BKDM4APDE9A
SCHEMBL21108339 0.92 CYP1A2 (0.40) HIF1AADORA1KDM4EHPGDADORA2A
SCHEMBL23487617 0.91 KDM4E (0.38) SMN1; SMN2HIF1AKDM5BKDM4APDE9A
SCHEMBL19942791 0.91 L3MBTL1 (0.44) L3MBTL1SMN1; SMN2HIF1AADORA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11492344-B2 Organic molecules for use in organic optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2022-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11492344-B2 Organic molecules for use in organic optoelectronic devices OR10J3, OCIAD2, OR51E2 L3MBTL1 3569/4885SMN1; SMN2 4516/4885HIF1A 3521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.